What is GLP-1 and How Does It Work?

Last reviewed: May 15, 2026 Last updated: May 15, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Your body produces a hormone called glucagon-like peptide-1 (GLP-1) that plays a critical role in managing blood sugar levels and controlling how hungry you feel throughout the day. Understanding how this hormone works can help you make informed decisions about weight management and metabolic health. PlexusDx specializes in precision GLP-1 therapy tailored to your unique genetic profile and health goals.

What is GLP-1: A Natural Hormone in Your Body

Your intestines release GLP-1 whenever you eat food, particularly when that meal contains protein or fat. This hormone acts as a chemical messenger, traveling through your bloodstream to communicate with your brain and pancreas about your nutritional status. Think of GLP-1 as an internal regulation system that keeps your body's energy balance in check.

The pancreas listens to GLP-1 signals and adjusts insulin production based on actual blood sugar levels at that moment. This response helps prevent dramatic spikes and crashes in glucose that can leave you feeling fatigued or irritable. Without adequate GLP-1 activity, your body struggles to maintain stable energy and metabolic function.

Scientists discovered that people with type 2 diabetes often have reduced GLP-1 activity, which means their natural hormone signaling is weaker than it should be. This discovery led to the development of medications that mimic or enhance GLP-1 effects, restoring more normal metabolic regulation in the body.

How GLP-1 Controls Blood Sugar and Metabolism

When blood glucose rises after eating, GLP-1 activates special receptors on insulin-producing cells in your pancreas. These cells then release the right amount of insulin needed to bring blood sugar back to a healthy range. This process happens automatically when GLP-1 signaling works properly, preventing the sharp fluctuations that damage blood vessels and organs over time.

GLP-1 also slows how quickly your stomach empties food into your small intestine, which means nutrients enter your bloodstream more gradually. This gradual absorption prevents the sudden glucose spikes that strain your pancreas and contribute to insulin resistance. By smoothing out nutrient delivery, GLP-1 helps maintain steadier energy levels throughout the day.

The hormone also enhances your liver's ability to take up glucose and store it as glycogen for later use. This reduces the amount of excess glucose circulating in your blood and eases the overall metabolic burden on your system. Research from the STEP trials showed that semaglutide, a GLP-1 medication, improved fasting blood sugar by an average of 25-30 mg/dL in patients with type 2 diabetes.

GLP-1 Medications: FDA-Approved Options and Compounded Solutions

The FDA has approved several GLP-1 receptor agonist medications for diabetes management, and some have also demonstrated significant weight loss benefits in clinical trials. Injectable versions like semaglutide are administered once weekly, while others come in daily oral formulations. PlexusDx offers both compounded semaglutide injections starting at $179 monthly and oral semaglutide from $209 monthly, all prepared by licensed 503A compounding pharmacies.

Tirzepatide, a newer dual glucose-dependent insulinotropic peptide and GLP-1 receptor agonist, targets two hormone pathways simultaneously for enhanced metabolic effects. The SURMOUNT trials demonstrated that tirzepatide produced weight loss ranging from 15% to 22% of body weight depending on dose, making it highly effective for weight management. PlexusDx provides compounded tirzepatide injections from $229 to $309 monthly and oral formulations from $229 to $509 monthly.

PlexusDx also offers the Microdose GLP-1 Protocol at $129 monthly for patients seeking gentler dosing strategies, and GLP-Squared, a dual compound combining multiple peptide mechanisms priced from $179 to $325 monthly. No insurance is required, and all medications work with HSA and FSA accounts, making precision GLP-1 therapy accessible to every patient across all 50 states.

How GLP-1 Reduces Appetite and Promotes Weight Loss

GLP-1 directly signals the appetite control centers in your brain's hypothalamus, triggering feelings of fullness and satisfaction even when you consume smaller portions. This neurological effect isn't about willpower or restriction—it's genuine biological signaling that makes you feel less driven to eat. Patients often report that food motivation decreases naturally, and eating becomes a logical choice rather than an overwhelming compulsion.

The hormone simultaneously reduces activity in reward pathways that make certain foods feel irresistible or emotionally comforting. This means cravings for high-calorie foods diminish not because you're fighting temptation, but because your brain's chemical reward system is rebalanced. This dual-action appetite suppression explains why GLP-1 therapy produces weight loss without the constant hunger that accompanies traditional calorie restriction.

By making you feel satisfied with less food, GLP-1 naturally creates a calorie deficit without conscious food counting or strict dieting. The STEP trials showed that semaglutide patients lost an average of 15% of body weight over 68 weeks, with many achieving sustained weight loss without regaining the weight after treatment. This durable weight loss happens because GLP-1 addresses the root biological drivers of overeating rather than relying on temporary behavior changes.

Genetic Insights: How PlexusDx Personalizes Your GLP-1 Therapy

Your genetic makeup influences how effectively your body responds to GLP-1 medications and what dosing strategy will work best for your unique biology. PlexusDx offers the Precision Peptide Genetic Test, available as a $99 add-on or $298 standalone, which analyzes your predispositions in peptide genetic pathways and evaluates 150+ genetic insights across 49 peptides and 14 different metabolic pathways.

Key genetic variants such as GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 shape how your cells respond to GLP-1 signaling and weight management interventions. Some people have genetic variations that enhance insulin sensitivity, while others have variants that amplify appetite suppression effects. Understanding your genetic profile allows PlexusDx to recommend the ideal medication type and dosing schedule for maximum results with minimal side effects.

This precision approach means you're not guessing about which medication will work or waiting months to discover if your current dose is optimal. Instead, PlexusDx uses your genetic predispositions to guide therapy selection from day one, accelerating your progress toward weight loss and metabolic health goals. Combined with clinical monitoring and dose adjustments, genetic insights create a truly personalized treatment plan aligned with your body's unique needs.

Frequently Asked Questions About What is GLP-1 and How Does It Work?

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.